Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Less toxic amounts of chemotherapy medicine slows tumor growth: Scientists

University of Georgia scientists have found that smaller, less toxic amounts of chemotherapy medicine given frequently to mice with human prostate cancer noticeably slowed tumor growth.

1 Oct 2011

Safeway introduces chain-wide breast cancer fundraising initiative

Safeway Inc. today launched its annual October chain-wide breast cancer fundraising initiative. The company has raised more than $94 million for the cause since 2001.

1 Oct 2011

Prostate cancer patients treated with CyberKnife Robotic Radiosurgery System enrolled in RPCR

The CyberKnife Coalition announced today that more than 500 men treated with the CyberKnife Robotic Radiosurgery System have now been enrolled in the first national patient registry designed specifically to track prostate cancer patients treated with stereotactic body radiation therapy.

1 Oct 2011

Estradiol plays an important role in several metabolic diseases

Hormone researchers at the University of Houston (UH) have their sights set on providing long-term treatment options for diabetes, obesity and cardiovascular diseases by better understanding estradiol, the most potent naturally occurring estrogen.

30 Sep 2011

Kimmel Cancer Center at Jefferson celebrates two decades of caring and collaboration to beat cancer

From October forward, the Kimmel Cancer Center at Jefferson (KCC), a National Cancer Institute-designated cancer center, is celebrating 20 years of service to the community and the groundbreaking cancer research from the scientists and physicians who've provided an invaluable contribution to medical science and healthcare.

30 Sep 2011

Large-scale study on cat intestinal cancer could ultimately benefit humans

A recent, large-scale study on cat intestinal cancer has provided new insight into a common pet disease and its causes; the findings could ultimately benefit humans.

29 Sep 2011

Simple low-cost method for isolation and collection of fragile prostate cancer cells

At the Oct. 2-6 microTAS 2011 conference, the premier international event for reporting research in microfluidics, nanotechnology and detection technologies for life science and chemistry, University of Cincinnati researchers will present a simple, low-cost, method for separating and safely collecting concentrated volumes of fragile prostate cancer cells.

29 Sep 2011

Scientists discover effective target to kill late-stage metastatic prostate cancer cells

Purdue University scientists believe they have found an effective target for killing late-stage, metastatic prostate cancer cells.

29 Sep 2011

Treatment of CMV infection can inhibit medullablastomas development

Researchers at Karolinska Institutet in Sweden have demonstrated for the first time that it is possible to inhibit the growth of brain tumours by treating the common Cytomegalovirus (CMV). The virus, which is found in a wide range of tumour types, offers a possible route towards controlling tumour growth and reducing the size of the tumour as a complement to conventional cytotoxin-based therapies.

28 Sep 2011

Sex therapy for prostate cancer after treatment may improve sex life: Study

Prostate cancer treatments can play havoc with men’s sex lives causing erectile dysfunction and other frustrating problems. For example, a recent study found about 60 percent of men with prostate cancer who had their prostate glands removed had not recovered their sexual function two years after their treatment. Many also lost some desire for sex and had a diminished ability to reach or enjoy orgasms. But new research shows that sex therapy can make a big difference.

27 Sep 2011

A Daddy’s heart is healthier: Study

A new study shows that fathers are less likely to die of heart disease than men who’ve never had kids. This raises questions about a possible biological link between male infertility and overall health. Other recent studies have found a connection between testicular and prostate cancer and infertility.

27 Sep 2011

Men with localized prostate cancer benefit from intensity modulated radiation therapy

Men with localized prostate cancer treated with a newer technology, intensity modulated radiation therapy (IMRT), have more than a quarter (26 percent) fewer late bowel and rectal side effects and a statistically improved lower dose of radiation to the bladder and rectum, compared to those who undergo 3D-CRT, according to a randomized study presented at the plenary session October 3, 2011, at the 53rd Annual Meeting of the American Society for Radiation Oncology.

27 Sep 2011

Photocure, Ipsen partner to commercialise Hexvix for diagnosis of bladder cancer

Ipsen announces today a partnership with Photocure, a specialty pharmaceutical company focused on photodynamic technologies in cancer and dermatology.

27 Sep 2011

Men over 75 with prostate cancer are being undertreated: Study

It's an ongoing debate: Should men over a certain age be treated for prostate cancer? Should these patients be submitted to treatments that may result in significant side effects if they may not live very much longer?

27 Sep 2011

World's first treatment of metastasized brain cancer uses IsoRay's Cesium-131 brachytherapy seeds

IsoRay, a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced today that doctors at New York Presbyterian Hospital/ Weill Cornell Medical Center have performed the world's first treatment of metastasized brain cancer using IsoRay's Cesium-131 brachytherapy seeds.

26 Sep 2011

Positive interim data from Aeterna Zentaris' AEZS-108 Phase 1/2 study on prostate cancer

Aeterna Zentaris Inc., today announced positive interim data for the Phase 1 portion of its ongoing Phase 1/2 study in castration and taxane-resistant prostate cancer with its targeted cytotoxic luteinizing hormone releasing hormone (LHRH) analog, AEZS-108.

26 Sep 2011

Ibandronate controls pain in prostate cancer patients with bone metastases

Many prostate cancer patients develop bone metastases, and controlling the pain these cause can be difficult. Now the first large randomised Phase III trial of a bisphosphonate drug in these patients has shown that a single dose of the drug is as good for pain relief as single dose radiotherapy, the standard treatment for bone metastases. Results of the trial were presented at the 2011 European Multidisciplinary Cancer Congress.

26 Sep 2011

Couples counseling can benefit prostate cancer patients' sex lives

Both internet-based counseling programs and face-to-face therapy sessions for couples improve the sex lives of prostate cancer survivors and their spouses. That is the finding of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society.

26 Sep 2011

Combination of abiraterone acetate, prednisone reduces fatigue in men with prostate cancer

Men with prostate cancer that has spread to other parts of the body and that is resistant to hormone therapy suffer less from fatigue if they are treated with a combination of abiraterone acetate and prednisone, according to results from a phase III clinical trial presented today.

26 Sep 2011

Genetic testing for breast and ovarian cancer

Experts from Cancer Treatment Centers of America (CTCA) provide some clues as to who should be using these tests. They explain that women who have been diagnosed with cancer and/or people who have a strong family history of cancer can consider genetic testing. Red flags to consider are anyone in the family who developed cancer at a young age, multiple family members who developed cancer, if a person experienced bilateral cancer (cancer in both breasts), breast and ovarian cancer in the same woman, or cancer appeared where it wasn’t expected (like breast cancer in men)

26 Sep 2011

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Less toxic amounts of chemotherapy medicine slows tumor growth: Scientists

Safeway introduces chain-wide breast cancer fundraising initiative

Prostate cancer patients treated with CyberKnife Robotic Radiosurgery System enrolled in RPCR

Estradiol plays an important role in several metabolic diseases

Kimmel Cancer Center at Jefferson celebrates two decades of caring and collaboration to beat cancer

Large-scale study on cat intestinal cancer could ultimately benefit humans

Simple low-cost method for isolation and collection of fragile prostate cancer cells

Scientists discover effective target to kill late-stage metastatic prostate cancer cells

Treatment of CMV infection can inhibit medullablastomas development

Sex therapy for prostate cancer after treatment may improve sex life: Study

A Daddy’s heart is healthier: Study

Men with localized prostate cancer benefit from intensity modulated radiation therapy

Photocure, Ipsen partner to commercialise Hexvix for diagnosis of bladder cancer

Men over 75 with prostate cancer are being undertreated: Study

World's first treatment of metastasized brain cancer uses IsoRay's Cesium-131 brachytherapy seeds

Positive interim data from Aeterna Zentaris' AEZS-108 Phase 1/2 study on prostate cancer

Ibandronate controls pain in prostate cancer patients with bone metastases

Couples counseling can benefit prostate cancer patients' sex lives

Combination of abiraterone acetate, prednisone reduces fatigue in men with prostate cancer

Genetic testing for breast and ovarian cancer

What to know about prostate cancer eBook

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Newsletters you may be interested in